Traws Pharma, Inc. Contract with Customer, Liability, Noncurrent
Traws Pharma, Inc. (TRAW) had Contract with Customer, Liability, Noncurrent of $2.51 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2026-04-15
- 2025-03-31: Contract with Customer, Liability, Noncurrent $2.51M.
- 2024-12-31: Contract with Customer, Liability, Noncurrent $2.56M.
- 2024-09-30: Contract with Customer, Liability, Noncurrent $2.62M.
- 2024-06-30: Contract with Customer, Liability, Noncurrent $2.68M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2025-03-31 | $2.51M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.56M 10-K · filed 2026-04-15 |
| 2024-09-30 | $2.62M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.68M 10-Q · filed 2024-08-15 |
| 2024-03-31 | $2.73M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.79M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.85M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.90M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.96M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.02M 10-K · filed 2024-04-01 |
| 2022-09-30 | $3.07M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.13M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.19M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $3.24M 10-K · filed 2023-03-30 |
| 2021-09-30 | $3.30M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.36M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $3.41M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $3.47M 10-K · filed 2022-03-21 |
| 2020-09-30 | $3.53M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $3.58M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $3.64M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $3.69M 10-K · filed 2021-03-18 |
| 2019-09-30 | $3.75M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.81M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $3.87M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $3.92M 10-K · filed 2020-03-27 |
| 2018-09-30 | $3.75M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $3.86M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $3.98M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $4.09M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |